Nasonex Indications/Uses

Mometasone furoate (NASONEX) Aqueous Nasal Spray is indicated for use in adults, adolescents, and children between the ages of 2 and 11 years to treat the symptoms of seasonal or perennial rhinitis.
In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with Mometasone furoate (NASONEX) Aqueous Nasal Spray is recommended two to four weeks prior to the anticipated start of the pollen season.
Mometasone furoate (NASONEX) Aqueous Nasal Spray is also indicated for the treatment of nasal polyps and associated symptoms including congestion and loss of smell in adult patients 18 years of age and older.
Mometasone furoate (NASONEX) Aqueous Nasal Spray is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of severe bacterial infection.
Mometasone furoate (NASONEX) Aqueous Nasal Spray is also indicated for use in adults and adolescents 12 years of age and older as adjunctive treatment to antibiotics for acute episodes of sinusitis.